Skip to main content
Premium Trial:

Request an Annual Quote

RainDance Inks Distribution Deals for Europe, Middle East

NEW YORK (GenomeWeb) – RainDance Technologies today announced several distribution agreements covering Europe and the Middle East. 

The deals are with BioTech-Europe, Diatech Pharmacogenetics, Labgene Scientific, and Neo-Science & Group. They will distribute RainDance products in Central and Eastern Europe, Italy, Switzerland, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates. 

RainDance's product portfolio includes the RainDrop Digital PCR system, the ThunderBolts NGS enrichment system, and the ThunderStorm NGS enrichment system. The Billerica, Mass.-based firm said the deals are part of its strategy to grow its presence in the liquid biopsy space outside the US. 

Sandy McBean, director of European sales for RainDance, added the firm is beginning to see acceleration in the adoption of its products in Europe and the Middle East "as more researchers look to pursue non-invasive liquid biopsy research for more accurate, reliable, cost-effective, and early detection of cancer and other complex diseases."  

BioTech-Europe, based in the Czech Republic, provides life science technologies to firms in Central and Eastern Europe. Diatech is a diagnostics company headquartered in Italyand develops pharmacogenetic tests with a focus on cancer and genetic disease treatments and therapies. 

Swiss firm Labgene commercializes products aimed at molecular biology laboratories, facilities, and platforms, and Dubai-based Neo-Science provides products and services to the life science research and clinical diagnostics space in the Middle East. 

Financial and other terms of the agreements were not disclosed.